Connect with us

BIOTECH

Biotech On Track To Develop Bio-Synthetic Cannabinoids

Published

on

InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF) released news Sept 25, 2017 revealing that the company had made breakthroughs in the scale-up and commercialization of the biosynthesis process for cannabinoid production.

IN/IMLFF noted that it can selectively produce all four “gateway” cannabinoids using genetically engineered microorganisms.   InMed President, Eric Adams, explained that through synthesis, IN/IMLFF could produce a variety of cannabinoids economically, which opens the door for new products.

Adams further noted that InMed was “dedicating substantial resources” to the commercialization of biosynthetic cannabinoid products.

Financials Trend began covering InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF) following its news on Sept 19, 2017, after announcing the filing of patents on biosynthesis of cannabinoids.  At the time we published that story, shares of InMed Pharmaceuticals rose 7% to $0.36.  Now, IN/IMLFF is trading at nearly $0.45.

We noted in our IN/IMLFF story that it was [BIG NEWS to the scientific community], but Mr. Adams clarified that further in yesterday’s press release when he explained how some extracts from marijuana are expensive to produce but through biosynthesis synthetic cannabinoids are just the opposite.

“The biosynthesis process opens up access to drug discovery and therapeutic use of all 90+ cannabinoids, most of which occur in only trace amounts in the plant and cannot be extracted in an economical fashion,” said Adams.

InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF) shares are trading up over 100% since Financials Trend first covered the company.  In that first article, we called InMed Pharmaceutical a “Five Bagger”, noting its gateway price of $0.21 at the time IN/IMLFF announced its patent applications and so far, it’s not disappointing our readers.  Our outlook hasn’t changed, yet we still stress patience in following IN/IMLFF progress.

 

Trading Symbol

OTC: MJMD

The Next Big Global Cannabis Trade




FEATURED STORIES

Business7 hours ago

Is it Time to Move Back into Hexo Corp (OTCMKTS:HYYDF)?

Hexo Corp (OTCMKTS:HYYDF) is one of the most interesting names in the cannabis space. There are only a few plays...

Business1 day ago

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Should Be on the Radar

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) shares closed last week by dipping under the key 50-day simple moving average to finish...

Business1 day ago

Will Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Start to Play Catch-up?

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) is an interesting play. The company has a massive stockpile of cash but hasn’t been...

Business1 day ago

Expansion Continues for Aphria Inc (OTCMKTS:APHQF), With Strong Catalysts Likely Ahead

Aphria Inc (OTCMKTS:APHQF) remains one our favorites primarily because it likely has some interesting catalysts ahead. It’s plausible to imagine...

Business2 days ago

What’s the Story Behind the Launch in Puration Inc (OTCMKTS:PURA) Shares?

Puration Inc (OTCMKTS:PURA) shares have been racing higher over the past month, and none of the catalysts contained in company...

Business2 days ago

How Medmen Enterprises Inc (OTCMKTS:MMNFF) is Positioned to Win on US Reform

Medmen Enterprises Inc (OTCMKTS:MMNFF) represents perhaps the cannabis company most likely to benefit the most from an eventual shift toward...

Business2 days ago

Hemp Inc (OTCMKTS:HEMP) Forges on as US Hemp Laws Progress

Hemp Inc (OTCMKTS:HEMP) recently announced that it applauds California’s commitment to agriculture, industrial hemp specifically, with the passing of SB...

Business3 days ago

Is New Age Beverages Corp (NASDAQ:NBEV) Setting Up for Some Interest From Above?

New Age Beverages Corp (NASDAQ:NBEV) is, as we see it, a very logical possibility for some kind of strategic interest,...

Business3 days ago

Why Aurora Cannabis Inc (OTCMKTS:ACBFF) is Set to Benefit from the Narrow US Market

Aurora Cannabis Inc (OTCMKTS:ACBFF) continues to be the top dog in the cannabis space as we see it. Capacity will...

Business4 days ago

Will Green Organic Dutchman Holdings Ltd (OTCMKTS:TGODF) Evolve From Prey to Predator?

Green Organic Dutchman Holdings Ltd (OTCMKTS:TGODF) has an extremely strong balance sheet at this point, with cash levels at $261.8M...

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: MJMD

The Next Big Global Cannabis Play